Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
2.510
+0.040 (1.62%)
At close: Apr 1, 2025, 4:00 PM
2.529
+0.019 (0.76%)
After-hours: Apr 1, 2025, 6:11 PM EDT

Acelyrin Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-248.23-381.64-64.77-41.84
Depreciation & Amortization
0.420.12--
Loss (Gain) From Sale of Assets
-5.63---
Asset Writedown & Restructuring Costs
-133.06-25
Loss (Gain) From Sale of Investments
-18.41-10.5-0.25-
Stock-Based Compensation
44.9647.324.050.23
Other Operating Activities
0.32-10.14-0.49-
Change in Accounts Payable
-37.0334.443.781.12
Change in Other Net Operating Assets
-40.3217.64-3.8410.51
Operating Cash Flow
-303.92-169.71-61.52-4.98
Capital Expenditures
-1.25-2.29--
Sale of Property, Plant & Equipment
7---
Cash Acquisitions
-10.01-0.08-
Sale (Purchase) of Intangibles
--10--25
Investment in Securities
149.11-445.46-47.79-
Investing Cash Flow
154.87-447.74-47.87-25
Issuance of Common Stock
7.33576.76-0.02
Repurchase of Common Stock
-1.94-8.33--
Other Financing Activities
--10.29-
Financing Cash Flow
5.39568.44274.26124.72
Net Cash Flow
-143.66-49.01164.8794.74
Free Cash Flow
-305.17-172-61.52-4.98
Free Cash Flow Per Share
-3.07-2.45-39.50-7.24
Levered Free Cash Flow
-216.69-250.17-36.41-
Unlevered Free Cash Flow
-216.69-250.17-36.41-
Change in Net Working Capital
77.41-55.39-2.78-
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q